| Viruses and Immune Responses: A Dynamical View | p. 1 |
| Viruses | p. 3 |
| Basic Immunological Background | p. 5 |
| Experimental Mouse Models of CTL Dynamics | p. 13 |
| Human Pathogenic Infections | p. 15 |
| Virus Dynamics and Mathematical Modeling | p. 18 |
| Immune Response Dynamics: Structure of the Book | p. 23 |
| Models of CTL Responses and Correlates of Virus Control | p. 25 |
| Virus Dynamics | p. 26 |
| Simplest Model for CTL Dynamics | p. 28 |
| Saturated CTL Expansion | p. 31 |
| Precursor Versus Effector CTL | p. 32 |
| Programmed CTL Proliferation | p. 34 |
| Summary | p. 40 |
| CTL Memory | p. 41 |
| The Generation of CTL Memory: Biological Background | p. 43 |
| Mathematical Models of CTL Memory | p. 43 |
| Resolution of Primary Infection: Mathematical Predictions | p. 45 |
| Resolution of Primary Infection: Experimental Studies | p. 47 |
| Protection Against Rechallenge: Mathematical Predictions | p. 49 |
| Protection Against Rechallenge: Experimental Studies | p. 51 |
| Summary | p. 53 |
| CD4 T Cell Help | p. 55 |
| Comparison of the Two Helper Pathways | p. 63 |
| How Does Help Work? | p. 63 |
| Infection Dynamics in Helper Deficient Hosts | p. 66 |
| Summary | p. 70 |
| Immunodominance | p. 71 |
| A Mathematical Model for Multiple CTL Clones | p. 72 |
| Theory and Data | p. 75 |
| An Unusual Pattern of Immunodominance | p. 77 |
| Summary | p. 84 |
| Multiple Infections and CTL Dynamics | p. 85 |
| Mathematical Model | p. 86 |
| Virus Control and Antigenic Heterogeneity | p. 87 |
| Two Heterologous Infections | p. 88 |
| Multiple Heterologous Infections | p. 90 |
| Experimental Studies | p. 93 |
| Coinfection: Viruses and Bacteria | p. 94 |
| Vaccination | p. 95 |
| The Immune Phenome and Aging | p. 96 |
| Summary | p. 97 |
| Control versus CTL-Induced Pathology | p. 99 |
| Basic Mathematical Insights | p. 100 |
| CTL-Induced Pathology in LCMV Infection | p. 103 |
| CTL-Induced Pathology and HIV Infection | p. 108 |
| Summary | p. 111 |
| Lytic versus Nonlytic Activity | p. 113 |
| Modeling Lytic and Nonlytic CTL Responses | p. 115 |
| Effect of Lytic and Nonlytic Immunity on Virus Control | p. 116 |
| Noncytopathic Viruses | p. 118 |
| More Cytopathic Viruses | p. 121 |
| Summary | p. 123 |
| Dynamical Interactions between CTL and Antibody Responses | p. 125 |
| Modeling Competition between CTL and Antibody Responses | p. 126 |
| Competition during Acute Infection | p. 128 |
| Effect of Viral Evolution during Chronic Infection | p. 129 |
| Application: Experimental Data on HCV Infection | p. 133 |
| Summary | p. 136 |
| Effector Molecules and CTL Homeostasis | p. 137 |
| CTL Homeostasis and Predator-Prey Dynamics | p. 138 |
| Effector Molecules and Immunodominance | p. 140 |
| The Role of Antigen for CTL Proliferation | p. 142 |
| Programmed CTL Proliferation and the Role of CTL Effectors | p. 143 |
| Effector Molecules and CTL Homeostasis in VSV Infection | p. 144 |
| Summary | p. 145 |
| Virus-Induced Subversion of CTL Responses | p. 147 |
| A Basic Model for Virus-Induced Impairment of Help | p. 149 |
| What Determines the Outcome of Infection? | p. 151 |
| Robustness of Predictions | p. 153 |
| Experimental Verification: CTL Exhaustion in LCMV Infection | p. 156 |
| Helper-Dependent versus Independent CTL Responses | p. 158 |
| Immune Impairment and the Level of Immune Responses | p. 163 |
| Summary | p. 165 |
| Boosting Immunity against Immunosuppressive Infections | p. 167 |
| Basic Properties of Immune Impairment | p. 168 |
| T Cell Dynamics during Therapy | p. 170 |
| Application: Early Treatment of SIV/HIV | p. 174 |
| Application: Treatment of HCV Infection | p. 178 |
| Treatment Interruptions | p. 179 |
| Summary | p. 181 |
| Evolutionary Aspects of Immunity | p. 183 |
| A Single Population of Pathogens | p. 184 |
| Two Competing Pathogen Populations | p. 186 |
| Pathogen Competition and the Evolution of Memory Duration | p. 188 |
| Application to Immunological Observations | p. 191 |
| Summary | p. 192 |
| References | p. 195 |
| Index | p. 217 |
| Table of Contents provided by Ingram. All Rights Reserved. |